Quarterly report pursuant to Section 13 or 15(d)

Income Tax (Details)

v3.21.2
Income Tax (Details) - USD ($)
9 Months Ended
Sep. 30, 2021
Dec. 31, 2020
Income Tax    
Unrecognized tax benefit $ 0 $ 0
Unrecognized income tax benefits impact on effective income tax rate 0 $ 0
Deferred income tax benefit 1,000,000.0  
Net operating loss carryforwards 135,214,763  
Pelican Therapeutics    
Income Tax    
Net operating loss carryforwards $ 3,027,284